Features: Magazine | Literary Review | Life | Metro Plus | Open Page | Education Plus | Book Review | Business | SciTech | NXg | Friday Review | Cinema Plus | Young World | Property Plus | Quest |

Massive vaccine trial

PHOTO: R. RAGU

RESEARCH: To find the elusive vaccine.

Researchers trying to create the world’s first malaria vaccine are launching a massive medical trial next month involving 16,000 children that could be the largest such trial ever conducted on children in Africa. British-drugmaker GlaxoSmithKline PLC is teaming with the PATH Malaria Vaccine Initiative, which is an anti-malaria charity funded by the Bill & Melinda Gates Foundation, and clinics and research centres in Africa to develop a malaria vaccine. Malaria, caused by parasites and spread by mosquitoes, kills nearly 1 million people every year, most of them children in Africa. The massive vaccine trials will be conducted in Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania.

Printer friendly page  
Send this article to Friends by E-Mail